Resmed Announces Participation in the Bank of America Global Healthcare Conference 2025
ResMed (NYSE: RMD) announced its participation in the upcoming Bank of America Global Healthcare Conference 2025 in London. Mick Farrell, chairman and CEO, and Dr. Carlos Nunez, chief medical officer, will present on September 23, 2025 at 1:20 p.m. BST.
The presentation will be available via audio-only webcast on the company's investor relations website, with replay access available for 30 days following the event.
ResMed (NYSE: RMD) ha annunciato la sua partecipazione alla prossima Bank of America Global Healthcare Conference 2025 a Londra. Mick Farrell, presidente e amministratore delegato, e Dr. Carlos Nunez, chief medical officer, terranno una presentazione il 23 settembre 2025 alle 13:20 BST.
La sessione sarà disponibile in webcast solo audio sul sito degli investitori dell’azienda, con replay accessibile per 30 giorni dopo l’evento.
ResMed (NYSE: RMD) anunció su participación en la próxima Bank of America Global Healthcare Conference 2025 en Londres. Mick Farrell, presidente y director ejecutivo, y Dr. Carlos Nunez, director médico, presentarán el 23 de septiembre de 2025 a las 13:20 BST.
La presentación estará disponible en webcast solo de audio en el sitio web de relaciones con inversores de la empresa, con acceso a la repetición durante 30 días tras el evento.
ResMed (NYSE: RMD)는 런던에서 열리는 다가오는 뱅크오브아메리카 글로벌 헬스케어 컨퍼런스 2025에 참석한다고 발표했습니다. Mick Farrell, 이사회 의장 겸 최고 경영 책임자, 및 Dr. Carlos Nunez, 최고의료책임자가 2025년 9월 23일 BST 오후 1시 20분에 발표할 예정입니다.
발표는 회사의 투자자 관계 웹사이트의 오디오 전용 생중계로 제공되며, 이벤트 종료 후 30일간 다시 들을 수 있습니다.
ResMed (NYSE: RMD) a annoncé sa participation à la prochaine Bank of America Global Healthcare Conference 2025 à Londres. Mick Farrell, président et directeur général, et Dr. Carlos Nunez, directeur médical, présenteront le 23 septembre 2025 à 13 h 20 BST.
La présentation sera disponible en webcast audio uniquement sur le site des relations investisseurs de l’entreprise, et pourra être réécoutée pendant 30 jours après l’événement.
ResMed (NYSE: RMD) hat seine Teilnahme an der kommenden Bank of America Global Healthcare Conference 2025 in London angekündigt. Mick Farrell, Vorstandsvorsitzender und CEO, und Dr. Carlos Nunez, Chief Medical Officer, werden am 23. September 2025 um 13:20 BST präsentieren.
Die Präsentation wird als reines Audio-Webcast auf der Website des Investor Relations des Unternehmens verfügbar sein, mit einer Wiedergabe für 30 Tage nach der Veranstaltung.
ResMed (NYSE: RMD) أعلنت عن مشاركتها في مؤتمر Bank of America Global Healthcare Conference 2025 الذي سيعقد في لندن. Mick Farrell، رئيس مجلس الإدارة والمدير التنفيذي، وDr. Carlos Nunez، المدير الطبي، سيقدمان في 23 سبتمبر 2025 الساعة 1:20 ظهرًا بتوقيت BST.
سيكون العرض متاحًا كجلسة ويب صوتية فقط على موقع علاقات المستثمرين للشركة، مع إمكانية إعادة التشغيل لمدة 30 يومًا بعد الحدث.
ResMed (NYSE: RMD)宣布将参与即将在伦敦举行的美银美林全球医疗保健大会2025。Mick Farrell,董事长兼首席执行官,以及Dr. Carlos Nunez,首席医疗官,将于2025年9月23日 BST 13:20进行演示。
此次演讲将通过公司投资者关系网站提供音频直播,事件结束后30天内可回放。
- None.
- None.
SAN DIEGO, Sept. 16, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chairman and chief executive officer, and Dr. Carlos Nunez, chief medical officer, will present at the Bank of America Global Healthcare Conference 2025 on Tuesday, September 23, 2025, beginning at approximately 1:20 p.m. (British Summer Time) in London.
More information about this event, including access to the live, audio-only webcast, may be accessed by visiting https://investor.resmed.com. The audio-only webcast replay will be available approximately 24 hours after the live webcast ends and will be accessible for the following thirty (30) days.
About Resmed
Resmed (NYSE: RMD, ASX: RMD) creates life-changing health technologies that people love. We’re relentlessly committed to pioneering innovative technology to empower millions of people in 140 countries to live happier, healthier lives. Our AI-powered digital health solutions, cloud-connected devices and intelligent software make home healthcare more personalized, accessible and effective. Ultimately, Resmed envisions a world where every person can achieve their full potential through better sleep and breathing, with care delivered in their own home. Learn more about how we’re redefining sleep health at Resmed.com and follow @Resmed.
For investors +1 858.221.3304 investorrelations@Resmed.com | For media +1 619.510.1281 news@Resmed.com | |
